Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study
Background—The etiology of abdominal aortic aneurysm (AAA) is complex. Cross-sectional studies have connected circulating biomarkers with AAA, but prospective evidence is limited.
Methods and Results—In the Atherosclerosis Risk in Communities Study cohort, we measured multiple blood biomarkers of inflammation, hemostasis, thrombin generation, cardiac dysfunction, and vascular stiffness and identified incident AAAs during follow-up using hospital discharge codes. Six biomarkers (white blood cell count, fibrinogen, D-dimer, troponin T, N-terminal pro-brain natriuretic peptide, and high sensitivity C-reactive protein) were strongly positively associated with AAA incidence. Compared with having none of these six biomarkers in the highest quartile, the hazard ratios of AAA for those with 1, 2, 3, or 4-6 biomarkers in the highest quartile were 2.2, 3.3, 4.0, and 9.9, respectively (p trend < 0.0001), adjusted for other risk factors.
Conclusions—This prospective study found that higher concentrations of six biomarkers were associated with increased risk of AAA. The more markers that fell into the highest quartile, the higher the AAA risk. Multiple positive biomarkers identify a subgroup of patients at high risk of AAA.
- Received March 16, 2015.
- Revision received June 5, 2015.
- Accepted June 10, 2015.